Screening for prostate cancer

被引：10

作者：

Neal, DE ^{[1
]}

Donovan, JL

机构：

[1] Univ Newcastle Upon Tyne, Sch Med, Sch Surg Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England

[2] Univ Bristol, Dept Social Med, Bristol, Avon, England

来源：

关键词：

prostate; prostate cancer; PSA; screening;

D O I：

10.1023/A:1008487912288

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1289 / 1292

页数：4

共 28 条

[1] ADOLFSSON J, 1993, CANCER-AM CANCER SOC, V72, P310, DOI 10.1002/1097-0142(19930715)72:2<310::AID-CNCR2820720203>3.0.CO
[2] 2-T
[3] The free-to-total prostate specific antigen ratio improves the specificity of prostate specific antigen in screening for prostate cancer in the general population
Bangma, CH
Rietbergen, JBW
Kranse, R
Blijenberg, BG
Petterson, K
Schroder, FH
[J]. JOURNAL OF UROLOGY, 1997, 157 (06) : 2191 - 2196
[4] ASSESSING THE EFFECTIVENESS OF COMMUNITY SCREENING PROGRAMS
CADMAN, D
CHAMBERS, L
FELDMAN, W
SACKETT, D
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 251 (12): : 1580 - 1585
[5] Prospective evaluation of men with stage T1c adenocarcinoma of the prostate
Carter, HB
Sauvageot, J
Walsh, PC
Epstein, JI
[J]. JOURNAL OF UROLOGY, 1997, 157 (06) : 2206 - 2209
[6] Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination - Enhancement of specificity with free PSA measurements
Catalona, WJ
Smith, DS
Ornstein, DK
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (18): : 1452 - 1455
[7] CHAMBERLAIN J, 1997, DIAGNOSIS MANAGEMENT, P1
[8] Collins MM, 1997, JAMA-J AM MED ASSOC, V278, P1516, DOI 10.1001/jama.278.18.1516
[9] COPLEN DE, 1991, J UROLOGY, V146, P757
[10] SYSTEMATIC SEXTANT BIOPSIES IN 651 PATIENTS REFERRED FOR PROSTATE EVALUATION
HAMMERER, P
HULAND, H
[J]. JOURNAL OF UROLOGY, 1994, 151 (01) : 99 - 102